---
schema_version: "secwatch.filing_event.v1"
accession: "0001522767-26-000164"
form_type: "8-K"
ticker: "MRMD"
cik: "0001522767"
company_name: "MARIMED INC."
filed_at: "2026-08-12T21:07:15+00:00"
generated_at: "2026-08-12T21:08:55.227116+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# MariMed Q2 2026 revenue up 6% to $41.9M; net loss widens to $3.6M

## Summary
- Revenue of $41.9M in Q2 2026, up 6% from $39.5M in Q2 2025; H1 revenue $81.4M vs $77.4M.
- GAAP net loss widened to $3.6M in Q2 vs $1.4M a year ago; non-GAAP net loss $2.4M vs $0.3M profit.
- Non-GAAP adjusted EBITDA fell to $3.9M (9% margin) from $4.8M (12% margin) in Q2 2025.
- GAAP gross margin 39% vs 40%; non-GAAP gross margin 40% vs 42%, down YoY.

## SEC filing metadata
- accession: 0001522767-26-000164
- form_type: 8-K
- ticker: MRMD
- cik: 0001522767
- company_name: MARIMED INC.
- filed_at: 2026-08-12T21:07:15+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000164/0001522767-26-000164-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000164/mrmd-20260812.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001522767-26-000164
- JSON: https://secwatch.observer/filing/0001522767-26-000164.json
- Plain text: https://secwatch.observer/filing/0001522767-26-000164.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.